Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. (Q50574947)

15 March 2018

meta-analysis

0 references

MDMA

0 references

title

Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. (English)

1 reference

15 March 2018

1 reference

Cédric M Hysek

1

1 reference

15 March 2018

Matthias E Liechti

series ordinal

2

1 reference

15 March 2018

publication date

15 June 2012

1 reference

15 March 2018

number of pages

14

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

15 March 2018

volume

224

1 reference

15 March 2018

issue

3

1 reference

15 March 2018

page(s)

363-376

1 reference

15 March 2018

https://scigraph.springernature.com/pub.10.1007/s00213-012-2761-6

exact match

0 references

cites work

Comparison of the effects of clonidine on tyramine- and methoxamine-evoked mydriasis in man.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Reversal of clonidine induced miosis by the alpha 2-adrenoreceptor antagonist RX 781094

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Clinical pharmacokinetics and pharmacodynamics of carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Effects of clonidine and yohimbine on the pupillary light reflex and carbachol-evoked sweating in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Two separate dose-dependent effects of paroxetine: mydriasis and inhibition of tramadol's O-demethylation via CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Effects of the noradrenergic agonist clonidine on temporal and spatial attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Comparison of the effects of clonidine and yohimbine on pupillary diameter at different illumination levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The Symptom Check-List-90-R (SCL-90-R): a German validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Contradictory effects of β1- and α1- aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)--CAVI independent of blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The effects of venlafaxine on autonomic functions in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Quantitative pupillometry, a new technology: normative data and preliminary observations in patients with acute head injury. Technical note

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Effects of reboxetine and desipramine on the kinetics of the pupillary light reflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2761-6

Alpha-adrenoceptor activation of nictitating membrane and iris in cats

21 January 2018

1 reference

12 December 2020

Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans

1 reference

12 December 2020

Clinical pharmacology of carvedilol

1 reference

12 December 2020

Atypical alpha-adrenoceptor mediates phenylephrine-induced mydriasis in anesthetized cats.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects

1 reference

12 December 2020

Pharmacokinetics and side-effects of clonidine

1 reference

12 December 2020

MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.

1 reference

12 December 2020

Comparison of the effects of clonidine and yohimbine on spontaneous pupillary fluctuations in healthy human volunteers

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension

1 reference

12 December 2020

Acute inositol does not attenuate m-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder

1 reference

12 December 2020

The role of norfenfluramine in fenfluramine-induced mydriasis

1 reference

12 December 2020

General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.

1 reference

12 December 2020

Carvedilol affects the physiological and behavioral response to smoked cocaine in humans

1 reference

12 December 2020

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

1 reference

12 December 2020

Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine

1 reference

12 December 2020

Autonomic components of the human pupillary light reflex

1 reference

12 December 2020

10.1007/S00213-012-2761-6

Identifiers

DOI

1 reference

15 March 2018

PubMed ID

22700038

1 reference

15 March 2018